Journal for ImmunoTherapy of Cancer (Nov 2023)
766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)